Warmuth Markus
SEC CIK 1855643 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics, Inc. | Pres, CEO, Dir | 585.0K | — | $951.1K | 9 | 2025-01-02 | 2026-07-16 |
Most active insiders at GLUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Janku Filip | Chief Medical Off | — | $1.38M |
| 2 | Warmuth Markus | Pres, CEO, Dir | — | $951.1K |
| 3 | Dunn Edmund | Principal Accounting Off | — | $483.1K |
| 4 | Townson Sharon | CSO | — | $423.9K |
| 5 | Manning Anthony M. | Dir | — | $411.2K |
| 6 | Champoux Jennifer | COO | — | $311.3K |
| 7 | Nickson Philip | Chief Business, Legal Off | — | $151.3K |
| 8 | Bowen Matthew | Principal Accounting Off | — | — |
| 9 | Behbahani Ali | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-17 16:05 | 2026-07-16 | GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | Pres, CEO, Dir | S - Sale | $23.18 | -9,500 | 585.0K | -2% | -$220.2K | |
| MT | 2026-06-02 16:05 | 2026-06-01 | GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | Pres, CEO, Dir | S - Sale | $19.44 | -5,466 | 594.5K | -0.9% | -$106.3K |
| T | 2026-05-05 16:05 | 2026-05-01 | GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | Pres, CEO, Dir | S - Sale | $18.92 | -5,467 | 600.0K | -0.9% | -$103.4K |
| 2026-04-15 16:05 | 2026-04-14 | GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | Pres, CEO, Dir | S - Sale | $17.64 | -8,000 | 605.5K | -1% | -$141.1K | |
| T | 2026-03-04 | 2026-03-02 | GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | Pres, CEO, Dir | S - Sale | $17.92 | -5,466 | 613.5K | -0.9% | -$98.0K |
| MT | 2026-01-09 | 2026-01-07 | GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | Pres, CEO, Dir | S - Sale | $23.48 | -5,466 | 620.7K | -0.9% | -$128.4K |
| D | 2026-01-05 | 2026-01-05 | GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | Pres, CEO, Dir | S - Sale | $15.17 | -10.1K | 624.4K | -2% | -$153.7K |
| D | 2026-01-05 | 2026-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | Pres, CEO, Dir | A - Grant | — | +90.0K | 634.5K | +17% | — |
| D | 2025-01-06 | 2025-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Warmuth Markus | Pres, CEO, Dir | A - Grant | — | +128.0K | 544.5K | +31% | — |
Purchase Sale Sale after option exercise All abbreviations